QCM
TARS icon

Quantinno Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Quantinno Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
5,111
+1,744
+52% +$111K ﹤0.01% 3180
2026
Q1 		$236K Buy
3,367
+622
+23% +$43.5K ﹤0.01% 3139
2025
Q4 		$225K Buy
+2,745
New +$205K ﹤0.01% 3001

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Quantinno Capital Management's TARS Position: Q2 2026 in Review

Quantinno Capital Management increased its Tarsus Pharmaceuticals (TARS) stake by 52% in Q2 2026, buying an estimated $111K and bringing the position to 5,111 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #3180.

Quantinno Capital Management first reported a position in TARS in Q4 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Quantinno Capital Management held 5,111 shares of Tarsus Pharmaceuticals worth $322K as of Q2 2026.
  • Quantinno Capital Management bought 1,744 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $111K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3180 holding.
  • Quantinno Capital Management first reported a position in Tarsus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.